Bristol-Myers Squibb Co
BMYMP
Company Profile
Business description
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
Contact
Sector
Healthcare
Stock type
Industry
Drug Manufacturers - General
Fiscal Year End
Employees
Bristol-Myers Squibb Co News & Analysis
stocks
What did Berkshire buy in Q3?
There were a few surprises in the wide-moat firm's 13-F filing.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,897.50 | 48.10 | 0.61% |
| CAC 40 | 7,957.57 | 42.92 | 0.54% |
| DAX 40 | 18,001.60 | 105.10 | 0.59% |
| Dow JONES (US) | 38,675.68 | 450.02 | 1.18% |
| FTSE 100 | 8,213.49 | 41.34 | 0.51% |
| HKSE | 18,475.92 | 268.79 | 1.48% |
| NASDAQ | 16,156.33 | 315.37 | 1.99% |
| Nikkei 225 | 38,236.07 | 37.98 | -0.10% |
| NZX 50 Index | 11,938.08 | 64.04 | 0.54% |
| S&P 500 | 5,127.79 | 63.59 | 1.26% |
| S&P/ASX 200 | 7,629.00 | 42.00 | 0.55% |
| SSE Composite Index | 3,104.82 | 8.22 | -0.26% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sigma Healthcare Ltd SIG | 1.30 | 0.04 | 3.19% |
| South32 Ltd S32 | 3.58 | 0.03 | 0.85% |
| Zip Co Ltd ZIP | 1.29 | 0.05 | 3.63% |
| Telstra Group Ltd TLS | 3.58 | 0.01 | -0.28% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 3.13% |
| Red 5 Ltd RED | 0.43 | 0.01 | -1.16% |
| Alumina Ltd AWC | 1.56 | 0.04 | 2.30% |
| Evolution Mining Ltd EVN | 3.73 | 0.22 | -5.57% |
| Pilbara Minerals Ltd PLS | 4.18 | 0.12 | 2.96% |
| The Star Entertainment Group Ltd SGR | 0.44 | 0.03 | 6.10% |